Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dialysis patients may benefit from ergothioneine supplement

NCT ID NCT06487546

First seen Feb 11, 2026 · Last updated May 21, 2026 · Updated 16 times

Summary

This study tests whether a daily ergothioneine supplement can restore low levels of this nutrient in the blood of people with kidney failure who are on dialysis. Dialysis removes waste but also strips away helpful substances like ergothioneine. The study will enroll 28 participants and measure changes in blood levels over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESRD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Veterans Affairs Palo Alto

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.